Published in
Nature Research, Nature Medicine, 6(25), p. 941-946, 2019
DOI: 10.1038/s41591-019-0448-9
Links
Tools
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma
Journal article published in 2019 by
Paolo Antonio Ascierto 
,
Pier Francesco Ferrucci ,
Rosalie Fisher,
Michele Del Vecchio,
Victoria Atkinson,
Henrik Schmidt,
Jacob Schachter,
Paola Queirolo,
Georgina V. Long ,
Anna Maria Di Giacomo,
Inge Marie Svane,
Michal Lotem,
Gil Bar-Sela,
Felix Couture,
Bijoyesh Mookerjee
and other authors.
,
Pier Francesco Ferrucci ,
Rosalie Fisher,
Michele Del Vecchio,
Victoria Atkinson,
Henrik Schmidt,
Jacob Schachter,
Paola Queirolo,
Georgina V. Long ,
Anna Maria Di Giacomo,
Inge Marie Svane,
Michal Lotem,
Gil Bar-Sela,
Felix Couture,
Bijoyesh Mookerjee
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 